15:01 IST
NSE
Earnings Call
Hester Biosciences Investor Presentation: Key Takeaways
Standalone revenue +28% Q2, +21% H1; PAT +131% Q2. EBITDA margin 35%, gross margin 78%. H1 consolidated PAT boosted by one-time Africa loan gain.